Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
This study has been completed.
Study NCT00074542   Information provided by Tillotts Pharma AG
First Received: December 15, 2003   Last Updated: February 20, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn's Disease
Additional conditions recognized in this trial
Crohn Disease
Enteritis
Ileitis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Ileal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
Epanova™ (Omega-3 Free Fatty Acids)
Sponsors listed in this trial
Tillotts Pharma AG


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services